Korean

R&D Highlights

R&D Pipeline
R&D
HOME >  R&D Highlights >  R&D

Multiple-Target Therapeutics Discovery

Multi-Component
Multi-Target (MCMT) approach

  • The ultimate goal of physicians and
    scientists is to improve and save lives.
    We owe it to present and future patients to explore
    all possible paths to achieving this goal.
    The pharmaceutical industry can do this
    by
    pursuing multi-target drugs as well as precision therapies

Cutting Edge CMC Technology

Intergrated approach for
Therapeutic Consistency

  • ·

    Standardization from Seed to Finished Product for
    Therapeutic Consistency

  • ·

    Technology Satisfying Totality of Evidence to Penetrate
    Advanced Global Market

AI-based Bio-Fingerprinting

Multi-Target-driven
Innovative Therapeutics

  • ·

    AI-Based Multi-Component Multi-Targeting Identification

  • ·

    Technology for Predicting Mode of Action

Omics

Microbiome & Metabolomics,
Omics

  • ·

    Correlation Identification Between 
    Chronic Refractory Diseases and Microbiota

  • ·

    New Candidate Discovery Based on Big Omics Data and
    Identification of Mode of Action